Financials • Investment Managers
$226.19 ▲ +3.65
(+1.64%)
MKT CAP: $8.26B • VOL: 218.0K
52W L $141 52W H $227
ROARABLE / RQD
B+ • 79/100
PIOTROSKI
7 / 9
MORN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.45B | $2.28B | $2.04B |
| YoY Revenue Growth % | +7.5% | +11.6% | — |
| Gross Profit | $1.49B | $1.38B | — |
| Gross Margin % | 61.0% | 60.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $526.6M | $484.8M | $230.6M |
| Operating Margin % | 21.5% | 21.3% | 11.3% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $644.3M | $599.0M | $304.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $589.7M | $591.6M | $316.4M |
| Capital Expenditures (CapEx) | $147.1M | $142.7M | $91.7M |
| Free Cash Flow (FCF) | $442.6M | $448.9M | $224.7M |
| FCF Margin % | 18.1% | 19.7% | 11.0% |
| Return on Invested Capital (ROIC %) | 22.9% | 21.1% | 6.6% |
| Cash & Short-Term Equivalents | $474.5M | $502.7M | — |
| Total Debt (Short + Long Term) | $1.07B | $698.6M | $1.06B |
| Total Stockholders' Equity | $1.22B | $1.62B | $2.18B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR MORN.